Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endocrinology | 37 | 2023 | 128 | 13.300 |
Why?
|
| Diabetes Mellitus | 37 | 2025 | 922 | 8.780 |
Why?
|
| Diabetes Mellitus, Type 1 | 23 | 2025 | 861 | 3.650 |
Why?
|
| Reference Standards | 35 | 2023 | 242 | 3.630 |
Why?
|
| Standard of Care | 35 | 2023 | 134 | 3.630 |
Why?
|
| Societies, Medical | 36 | 2023 | 778 | 2.860 |
Why?
|
| Food Hypersensitivity | 5 | 2020 | 167 | 2.530 |
Why?
|
| Transition to Adult Care | 7 | 2025 | 119 | 1.800 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2023 | 1408 | 1.530 |
Why?
|
| Diabetic Ketoacidosis | 3 | 2025 | 166 | 1.100 |
Why?
|
| Allergens | 4 | 2020 | 276 | 0.980 |
Why?
|
| Fossils | 3 | 2020 | 13 | 0.950 |
Why?
|
| Immunoglobulin E | 3 | 2020 | 180 | 0.910 |
Why?
|
| Humans | 75 | 2025 | 132105 | 0.780 |
Why?
|
| Retinal Diseases | 2 | 2023 | 179 | 0.780 |
Why?
|
| Insulin | 5 | 2022 | 1168 | 0.700 |
Why?
|
| Mammals | 3 | 2019 | 271 | 0.700 |
Why?
|
| Juglans | 1 | 2020 | 1 | 0.680 |
Why?
|
| Biodiversity | 2 | 2020 | 87 | 0.670 |
Why?
|
| Nuts | 1 | 2020 | 17 | 0.670 |
Why?
|
| Extinction, Biological | 2 | 2019 | 4 | 0.670 |
Why?
|
| Blood Glucose | 7 | 2023 | 1121 | 0.660 |
Why?
|
| Hypoglycemic Agents | 8 | 2023 | 482 | 0.620 |
Why?
|
| Human Activities | 2 | 2016 | 9 | 0.610 |
Why?
|
| Prescription Drugs | 1 | 2020 | 54 | 0.610 |
Why?
|
| Ecosystem | 2 | 2019 | 107 | 0.610 |
Why?
|
| Europe | 4 | 2020 | 372 | 0.600 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2018 | 13 | 0.590 |
Why?
|
| Hyperglycemia | 1 | 2020 | 234 | 0.550 |
Why?
|
| Mycelium | 1 | 2017 | 1 | 0.540 |
Why?
|
| Agar | 1 | 2017 | 18 | 0.530 |
Why?
|
| Microbial Interactions | 1 | 2017 | 16 | 0.530 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 277 | 0.520 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2023 | 803 | 0.510 |
Why?
|
| Candida | 1 | 2017 | 84 | 0.500 |
Why?
|
| Plant Physiological Phenomena | 1 | 2015 | 8 | 0.490 |
Why?
|
| Agriculture | 1 | 2015 | 32 | 0.480 |
Why?
|
| Dyslipidemias | 1 | 2018 | 242 | 0.470 |
Why?
|
| Adolescent | 22 | 2025 | 20532 | 0.440 |
Why?
|
| Blood Glucose Self-Monitoring | 4 | 2023 | 124 | 0.410 |
Why?
|
| Adolescent Development | 1 | 2013 | 33 | 0.410 |
Why?
|
| Child | 18 | 2025 | 25758 | 0.410 |
Why?
|
| Asthma | 1 | 2020 | 771 | 0.400 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 2059 | 0.380 |
Why?
|
| Biological Evolution | 3 | 2020 | 243 | 0.370 |
Why?
|
| Adult | 22 | 2025 | 31557 | 0.360 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 742 | 0.360 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 723 | 0.350 |
Why?
|
| Young Adult | 14 | 2025 | 9940 | 0.340 |
Why?
|
| Comorbidity | 4 | 2023 | 1606 | 0.320 |
Why?
|
| Prevalence | 4 | 2021 | 2659 | 0.320 |
Why?
|
| Dogs | 2 | 2020 | 651 | 0.310 |
Why?
|
| Physicians | 1 | 2015 | 637 | 0.290 |
Why?
|
| Clinical Competence | 1 | 2015 | 1071 | 0.280 |
Why?
|
| Female | 24 | 2025 | 70680 | 0.270 |
Why?
|
| Cross-Sectional Studies | 7 | 2021 | 3738 | 0.270 |
Why?
|
| Patient Preference | 2 | 2018 | 136 | 0.250 |
Why?
|
| Genetic Testing | 3 | 2018 | 1098 | 0.250 |
Why?
|
| Male | 17 | 2025 | 64918 | 0.240 |
Why?
|
| Southwestern United States | 1 | 2025 | 45 | 0.230 |
Why?
|
| Live Birth | 1 | 2025 | 72 | 0.230 |
Why?
|
| Protective Factors | 1 | 2025 | 90 | 0.230 |
Why?
|
| Body Size | 2 | 2016 | 68 | 0.230 |
Why?
|
| Insulin Infusion Systems | 3 | 2020 | 66 | 0.220 |
Why?
|
| Affect | 1 | 2025 | 173 | 0.220 |
Why?
|
| Hypertriglyceridemia | 1 | 2025 | 114 | 0.210 |
Why?
|
| Peer Group | 1 | 2024 | 121 | 0.210 |
Why?
|
| Climate Change | 2 | 2020 | 63 | 0.200 |
Why?
|
| Mentors | 1 | 2024 | 164 | 0.200 |
Why?
|
| Sleep Wake Disorders | 1 | 2025 | 197 | 0.200 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2025 | 896 | 0.190 |
Why?
|
| Liraglutide | 1 | 2022 | 15 | 0.190 |
Why?
|
| Child, Preschool | 6 | 2025 | 14718 | 0.190 |
Why?
|
| Animals | 8 | 2020 | 34953 | 0.190 |
Why?
|
| Hospitals | 2 | 2023 | 438 | 0.190 |
Why?
|
| Quality Improvement | 3 | 2023 | 698 | 0.190 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 74 | 0.190 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2023 | 137 | 0.180 |
Why?
|
| Recurrence | 1 | 2025 | 1454 | 0.180 |
Why?
|
| Uterus | 1 | 2025 | 547 | 0.170 |
Why?
|
| Breast Neoplasms | 3 | 2018 | 2683 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 479 | 0.170 |
Why?
|
| Antigens, Plant | 1 | 2020 | 42 | 0.170 |
Why?
|
| Cats | 1 | 2020 | 118 | 0.170 |
Why?
|
| Stress, Psychological | 1 | 2025 | 578 | 0.160 |
Why?
|
| Cross Reactions | 1 | 2020 | 190 | 0.160 |
Why?
|
| Population Dynamics | 2 | 2019 | 34 | 0.160 |
Why?
|
| Vaccination | 1 | 2025 | 1017 | 0.160 |
Why?
|
| Autoantibodies | 1 | 2022 | 458 | 0.150 |
Why?
|
| Health Personnel | 1 | 2024 | 545 | 0.150 |
Why?
|
| Pregnancy | 5 | 2025 | 7551 | 0.150 |
Why?
|
| Diabetes Complications | 1 | 2020 | 206 | 0.150 |
Why?
|
| North America | 2 | 2019 | 265 | 0.150 |
Why?
|
| Infant | 3 | 2025 | 13039 | 0.150 |
Why?
|
| Passeriformes | 1 | 2008 | 2 | 0.140 |
Why?
|
| Breast Feeding | 1 | 2020 | 233 | 0.140 |
Why?
|
| Food | 1 | 2019 | 127 | 0.140 |
Why?
|
| Spatial Behavior | 1 | 2008 | 13 | 0.140 |
Why?
|
| Reproductive Health | 1 | 2018 | 49 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2021 | 251 | 0.140 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 55 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 3358 | 0.140 |
Why?
|
| Health Communication | 1 | 2018 | 31 | 0.140 |
Why?
|
| Prokaryotic Cells | 1 | 2017 | 8 | 0.140 |
Why?
|
| Eukaryota | 1 | 2017 | 24 | 0.130 |
Why?
|
| Farnesol | 1 | 2017 | 4 | 0.130 |
Why?
|
| Infant, Newborn | 3 | 2025 | 8538 | 0.130 |
Why?
|
| Candida glabrata | 1 | 2017 | 19 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 323 | 0.130 |
Why?
|
| Phenylethyl Alcohol | 1 | 2017 | 30 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 3083 | 0.130 |
Why?
|
| Health Education | 1 | 2018 | 235 | 0.130 |
Why?
|
| Islands | 1 | 2016 | 5 | 0.130 |
Why?
|
| Culture Media | 1 | 2017 | 182 | 0.130 |
Why?
|
| Candida albicans | 1 | 2017 | 90 | 0.130 |
Why?
|
| Life Cycle Stages | 1 | 2016 | 26 | 0.130 |
Why?
|
| Depression | 1 | 2025 | 1351 | 0.120 |
Why?
|
| Decision Making | 2 | 2018 | 694 | 0.120 |
Why?
|
| History, Ancient | 1 | 2015 | 56 | 0.120 |
Why?
|
| Indoles | 1 | 2017 | 201 | 0.120 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 3982 | 0.120 |
Why?
|
| Disclosure | 1 | 2016 | 153 | 0.120 |
Why?
|
| Risk Factors | 3 | 2025 | 10902 | 0.120 |
Why?
|
| Behavior, Animal | 1 | 2008 | 506 | 0.110 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1653 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1176 | 0.110 |
Why?
|
| Pediatrics | 2 | 2014 | 1208 | 0.110 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2014 | 34 | 0.110 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 97 | 0.110 |
Why?
|
| Psychology, Adolescent | 1 | 2013 | 35 | 0.100 |
Why?
|
| Phylogeny | 1 | 2016 | 762 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 3021 | 0.100 |
Why?
|
| Obesity | 2 | 2023 | 2396 | 0.100 |
Why?
|
| Puberty | 1 | 2013 | 104 | 0.100 |
Why?
|
| Family | 1 | 2016 | 594 | 0.100 |
Why?
|
| Patient Care Planning | 1 | 2013 | 130 | 0.100 |
Why?
|
| Hospitalization | 1 | 2021 | 1891 | 0.100 |
Why?
|
| Hypertension | 1 | 2020 | 1388 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3418 | 0.090 |
Why?
|
| Adolescent Behavior | 1 | 2013 | 171 | 0.090 |
Why?
|
| United States | 4 | 2021 | 11627 | 0.090 |
Why?
|
| Learning | 3 | 2020 | 370 | 0.090 |
Why?
|
| Social Support | 1 | 2013 | 386 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2013 | 359 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 461 | 0.080 |
Why?
|
| Self Care | 2 | 2024 | 227 | 0.080 |
Why?
|
| Time Factors | 2 | 2018 | 6445 | 0.080 |
Why?
|
| Aged | 3 | 2023 | 21413 | 0.070 |
Why?
|
| Age Factors | 3 | 2021 | 2922 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1306 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2013 | 801 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2025 | 17374 | 0.060 |
Why?
|
| Australia | 1 | 2025 | 185 | 0.060 |
Why?
|
| Registries | 2 | 2021 | 1589 | 0.050 |
Why?
|
| Pancreatitis | 1 | 2025 | 141 | 0.050 |
Why?
|
| Benchmarking | 1 | 2023 | 137 | 0.050 |
Why?
|
| Quality of Life | 2 | 2024 | 2152 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2018 | 13017 | 0.050 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2021 | 18 | 0.050 |
Why?
|
| Middle Aged | 2 | 2019 | 28936 | 0.050 |
Why?
|
| Off-Label Use | 1 | 2021 | 29 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2025 | 672 | 0.040 |
Why?
|
| Parity | 1 | 2020 | 85 | 0.040 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2020 | 39 | 0.040 |
Why?
|
| Sodium | 1 | 2021 | 296 | 0.040 |
Why?
|
| Biomarkers | 2 | 2021 | 3380 | 0.040 |
Why?
|
| Paleontology | 1 | 2019 | 2 | 0.040 |
Why?
|
| Health Behavior | 1 | 2023 | 398 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 656 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2023 | 572 | 0.040 |
Why?
|
| Age of Onset | 1 | 2020 | 626 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 1246 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 398 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2021 | 880 | 0.040 |
Why?
|
| Orientation | 1 | 2008 | 47 | 0.030 |
Why?
|
| Space Perception | 1 | 2008 | 59 | 0.030 |
Why?
|
| Cues | 1 | 2008 | 101 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 899 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2020 | 329 | 0.030 |
Why?
|
| Triglycerides | 1 | 2020 | 617 | 0.030 |
Why?
|
| Glucose | 1 | 2021 | 878 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 606 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2023 | 802 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2016 | 49 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2016 | 61 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 765 | 0.030 |
Why?
|
| Counseling | 1 | 2016 | 233 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2227 | 0.030 |
Why?
|
| Genetic Counseling | 1 | 2016 | 246 | 0.030 |
Why?
|
| Atmosphere | 1 | 2014 | 4 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 1451 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2023 | 5399 | 0.030 |
Why?
|
| Temperature | 1 | 2014 | 305 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2306 | 0.020 |
Why?
|
| Communication | 1 | 2016 | 540 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 3714 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 5008 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 670 | 0.020 |
Why?
|
| Oxygen | 1 | 2014 | 571 | 0.020 |
Why?
|
| Texas | 1 | 2018 | 3630 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7119 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 6249 | 0.010 |
Why?
|